$LEU
CENTRUS ENERGY CORP Stock $leu

$leu Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000106505922000012 Filed on March 11, 2022

Income Statement

Concept	2021 Q4	2021	2020 Q4
Revenue	$89.00M	$298.3M	$92.90M
YoY Change	-4.2%	20.67%	66.79%
Cost Of Revenue	$52.80M	$183.8M	$57.90M
YoY Change	-8.81%	22.86%	18.4%
Gross Profit	$36.20M	$114.5M	$35.00M
YoY Change	3.43%	17.32%	414.71%
Gross Profit Margin	40.67%	38.38%	37.67%
Selling, General & Admin	$11.00M	$36.00M	$10.40M
YoY Change	5.77%	0.0%	13.04%
% of Gross Profit	30.39%	31.44%	29.71%
Research & Development	$800.0K	$2.100M	$1.000M
YoY Change	-20.0%	-25.0%	-37.5%
% of Gross Profit	2.21%	1.83%	2.86%
Depreciation & Amortization	$2.800M	$8.600M	$2.600M
YoY Change	7.69%	17.81%	4.0%
% of Gross Profit	7.73%	7.51%	7.43%
Operating Expenses	$14.50M	$38.10M	$11.40M
YoY Change	27.19%	-1.8%	5.56%
Operating Profit	$21.70M	$68.30M	$20.60M
YoY Change	5.34%	33.92%	-407.46%
Interest Expense	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
% of Operating Profit	0.0%	0.0%	0.0%
Other Income/Expense, Net	$54.70M	$67.60M	-$5.000M
YoY Change	-1194.0%	4125.0%	-221.95%
Pretax Income	$76.40M	$135.9M	$15.60M
YoY Change	389.74%	156.42%	-750.0%
Income Tax	-$39.80M	-$39.10M	-$800.0K
% Of Pretax Income	-52.09%	-28.77%	-5.13%
Net Earnings	$116.2M	$175.0M	$16.40M
YoY Change	608.54%	221.69%	-685.71%
Net Earnings / Revenue	130.56%	58.67%	17.65%
Basic Earnings Per Share		$10.03	-$2.55
Diluted Earnings Per Share	$8.064M	$9.75	-$2.55
COMMON SHARES
Basic Shares Outstanding		13.49M shares	11.32M shares
Diluted Shares Outstanding		13.88M shares

Balance Sheet

Concept	2021 Q4	2021	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$193.8M	$193.8M	$152.0M
YoY Change	27.5%	27.5%	16.3%
Cash & Equivalents	$193.8M	$193.8M	$152.0M
Short-Term Investments
Other Short-Term Assets	$8.600M	$8.600M	$7.800M
YoY Change	10.26%	10.26%	-15.22%
Inventory	$91.10M	$91.10M	$64.80M
Prepaid Expenses
Receivables	$29.10M	$149.3M	$29.60M
Other Receivables	$23.10M	$23.10M	$23.00M
Total Short-Term Assets	$465.9M	$465.9M	$406.1M
YoY Change	14.73%	14.73%	9.88%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.300M	$7.400M	$4.900M
YoY Change	8.16%	-22.11%	32.43%
Goodwill
YoY Change
Intangibles	$54.70M		$62.80M
YoY Change	-12.9%		-9.64%
Long-Term Investments
YoY Change
Other Assets	$2.300M	$44.40M	$4.900M
YoY Change	-53.06%	462.03%	-33.78%
Total Long-Term Assets	$106.5M	$106.5M	$80.20M
YoY Change	32.79%	32.79%	-7.07%
TOTAL ASSETS
Total Short-Term Assets	$465.9M	$465.9M	$406.1M
Total Long-Term Assets	$106.5M	$106.5M	$80.20M
Total Assets	$572.4M	$572.4M	$486.3M
YoY Change	17.71%	17.71%	6.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$37.80M	$4.900M	$21.30M
YoY Change	77.46%	0.0%	162.96%
Accrued Expenses		$25.90M	$50.60M
YoY Change		-24.05%	-0.2%
Deferred Revenue	$303.1M		$283.2M
YoY Change	7.03%		6.35%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Long-Term Debt Due	$6.100M	$6.100M	$6.100M
YoY Change	0.0%	0.0%	0.0%
Total Short-Term Liabilities	$393.3M	$393.3M	$366.1M
YoY Change	7.43%	7.43%	8.7%
LONG-TERM LIABILITIES
Long-Term Debt	$101.8M	$101.8M	$108.0M
YoY Change	-5.74%	-5.74%	-5.35%
Other Long-Term Liabilities	$13.70M	$219.2M	$32.40M
YoY Change	-57.72%	-34.13%	0.93%
Total Long-Term Liabilities	$13.70M	$321.0M	$32.40M
YoY Change	-57.72%	-27.18%	-95.91%
TOTAL LIABILITIES
Total Short-Term Liabilities	$393.3M	$393.3M	$366.1M
Total Long-Term Liabilities	$13.70M	$321.0M	$32.40M
Total Liabilities	$714.3M	$714.3M	$806.9M
YoY Change	-11.48%	-11.48%	1.78%
SHAREHOLDERS EQUITY
Retained Earnings	-$284.6M		-$407.7M
YoY Change	-30.19%		0.67%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$141.9M	-$141.9M	-$320.6M
YoY Change
Total Liabilities & Shareholders Equity	$572.4M	$572.4M	$486.3M
YoY Change	17.71%	17.71%	6.67%

Cashflow Statement

Concept	2021 Q4	2021	2020 Q4
OPERATING ACTIVITIES
Net Income	$116.2M	$175.0M	$16.40M
YoY Change	608.54%	221.69%	-685.71%
Depreciation, Depletion And Amortization	$2.800M	$8.600M	$2.600M
YoY Change	7.69%	17.81%	4.0%
Cash From Operating Activities	$49.20M	$50.00M	$61.90M
YoY Change	-20.52%	-25.48%	63.76%
INVESTING ACTIVITIES
Capital Expenditures	-$500.0K	$1.200M	-$500.0K
YoY Change	0.0%	-14.29%	400.0%
Acquisitions
YoY Change
Other Investing Activities			$0.00
YoY Change
Cash From Investing Activities	-$500.0K	-$1.200M	-$500.0K
YoY Change	0.0%	-14.29%	400.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$42.10M
YoY Change		82.25%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-28.80M	-$9.900M	-62.20M
YoY Change	-53.7%	-77.7%	5083.33%
NET CHANGE
Cash From Operating Activities	49.20M	$50.00M	61.90M
Cash From Investing Activities	-500.0K	-$1.200M	-500.0K
Cash From Financing Activities	-28.80M	-$9.900M	-62.20M
Net Change In Cash	19.90M	$38.90M	-800.0K
YoY Change	-2587.5%	82.63%	-102.19%
FREE CASH FLOW
Cash From Operating Activities	$49.20M	$50.00M	$61.90M
Capital Expenditures	-$500.0K	$1.200M	-$500.0K
Free Cash Flow	$49.70M	$48.80M	$62.40M
YoY Change	-20.35%	-25.72%	64.64%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0001065059
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1.00
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2021	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P7Y9M
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent
CY2021Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#AccountsPayableAndAccruedLiabilitiesCurrent
CY2020Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#AccountsPayableAndAccruedLiabilitiesCurrent
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Entity File Number EntityFileNumber	1-14287
CY2021	dei	Entity Registrant Name EntityRegistrantName	Centrus Energy Corp.
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	52-2107911
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	6901 Rockledge Drive, Suite 800
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	Bethesda
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	MD
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	20817
CY2021	dei	City Area Code CityAreaCode	(301)
CY2021	dei	Local Phone Number LocalPhoneNumber	564-3200
CY2021	dei	Security12b Title Security12bTitle	Class A Common Stock, par value $0.10 per share
CY2021	dei	Trading Symbol TradingSymbol	LEU
CY2021	dei	Security Exchange Name SecurityExchangeName	NYSEAMER
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Small Business EntitySmallBusiness	true
CY2021	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Public Float EntityPublicFloat	257900000	USD
CY2022Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	13673933	shares
CY2021	dei	Auditor Firm AuditorFirmId	238
CY2021	dei	Auditor Name AuditorName	PricewaterhouseCoopers LLP
CY2021	dei	Auditor Location AuditorLocation	Baltimore, Maryland
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	152000000.0	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	29100000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	29600000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	91100000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	64800000	USD
CY2021Q4	us-gaap	Other Deferred Costs Net OtherDeferredCostsNet	143300000	USD
CY2020Q4	us-gaap	Other Deferred Costs Net OtherDeferredCostsNet	151900000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	8600000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7800000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	465900000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	406100000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5300000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4900000	USD
CY2021Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	2800000	USD
CY2020Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	5700000	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	54700000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	62800000	USD
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	41400000	USD
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1900000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2300000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4900000	USD
CY2021Q4	us-gaap	Assets Assets	572400000	USD
CY2020Q4	us-gaap	Assets Assets	486300000	USD
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	37800000	USD
CY2020Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	50600000	USD
CY2021Q4	leu	Accounts Payable Under Purchase Agreements Current AccountsPayableUnderPurchaseAgreementsCurrent	37900000	USD
CY2020Q4	leu	Accounts Payable Under Purchase Agreements Current AccountsPayableUnderPurchaseAgreementsCurrent	21300000	USD
CY2021Q4	leu	Inventories Owed To Customers And Suppliers InventoriesOwedToCustomersAndSuppliers	8400000	USD
CY2020Q4	leu	Inventories Owed To Customers And Suppliers InventoriesOwedToCustomersAndSuppliers	4900000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	303100000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	283200000	USD
CY2021Q4	us-gaap	Debt Current DebtCurrent	6100000	USD
CY2020Q4	us-gaap	Debt Current DebtCurrent	6100000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	393300000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	366100000	USD
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	101800000	USD
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	108000000.0	USD
CY2021Q4	us-gaap	Other Postretirement Defined Benefit Plan Liabilities Noncurrent OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent	114900000	USD
CY2020Q4	us-gaap	Other Postretirement Defined Benefit Plan Liabilities Noncurrent OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent	130800000	USD
CY2021Q4	us-gaap	Defined Benefit Pension Plan Liabilities Noncurrent DefinedBenefitPensionPlanLiabilitiesNoncurrent	23100000	USD
CY2020Q4	us-gaap	Defined Benefit Pension Plan Liabilities Noncurrent DefinedBenefitPensionPlanLiabilitiesNoncurrent	124400000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	45100000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	45200000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	36100000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	32400000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	714300000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	806900000	USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1.00
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	140700000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	85000000.0	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-284600000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-407700000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	500000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	800000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-141900000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-320600000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	572400000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	486300000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	298300000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	247200000	USD
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	183800000	USD
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	149600000	USD
CY2021	us-gaap	Gross Profit GrossProfit	114500000	USD
CY2020	us-gaap	Gross Profit GrossProfit	97600000	USD
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2100000	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2800000	USD
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	36000000.0	USD
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	36000000.0	USD
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	8100000	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6800000	USD
CY2021	us-gaap	Restructuring Charges RestructuringCharges	0	USD
CY2020	us-gaap	Restructuring Charges RestructuringCharges	600000	USD
CY2021	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	0	USD
CY2020	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-400000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	68300000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	51000000.0	USD
CY2021	us-gaap	Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent	-67600000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-39100000	USD
CY2020	us-gaap	Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent	-1600000	USD
CY2021	us-gaap	Interest Expense Debt InterestExpenseDebt	100000	USD
CY2020	us-gaap	Interest Expense Debt InterestExpenseDebt	100000	USD
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	100000	USD
CY2020	us-gaap	Investment Income Interest InvestmentIncomeInterest	500000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	135900000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	53000000.0	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1400000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	175000000.0	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	54400000	USD
CY2021	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	2100000	USD
CY2020	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	6700000	USD
CY2021	us-gaap	Other Preferred Stock Dividends And Adjustments OtherPreferredStockDividendsAndAdjustments	37600000	USD
CY2021	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	37600000	USD
CY2020	us-gaap	Other Preferred Stock Dividends And Adjustments OtherPreferredStockDividendsAndAdjustments	41900000	USD
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9825000	shares
CY2020	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	41900000	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	135300000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	5800000	USD
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	10.03
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.59
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	9.75
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.57
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13493000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13879000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10123000	shares
CY2021	us-gaap	Net Income Loss NetIncomeLoss	175000000.0	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	54400000	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	8600000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	7300000	USD
CY2021	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination	7200000	USD
CY2020	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination	10600000	USD
CY2021	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	39500000	USD
CY2020	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	1900000	USD
CY2021	us-gaap	Defined Benefit Plan Actuarial Gain Loss DefinedBenefitPlanActuarialGainLoss	50500000	USD
CY2020	us-gaap	Defined Benefit Plan Actuarial Gain Loss DefinedBenefitPlanActuarialGainLoss	-7200000	USD
CY2021	us-gaap	Other Noncash Expense OtherNoncashExpense	4800000	USD
CY2020	us-gaap	Other Noncash Expense OtherNoncashExpense	0	USD
CY2021	leu	Equity Related Compensation EquityRelatedCompensation	12100000	USD
CY2020	leu	Equity Related Compensation EquityRelatedCompensation	7100000	USD
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-500000	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	8600000	USD
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	10700000	USD
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-25800000	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	16600000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	13200000	USD
CY2021	leu	Increase Decreasein Deferred Revenue Netof Deferred Costs IncreaseDecreaseinDeferredRevenueNetofDeferredCosts	13200000	USD
CY2020	leu	Increase Decreasein Deferred Revenue Netof Deferred Costs IncreaseDecreaseinDeferredRevenueNetofDeferredCosts	9700000	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-4600000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-5200000	USD
CY2021	us-gaap	Increase Decrease In Pension Plan Obligations IncreaseDecreaseInPensionPlanObligations	-67000000.0	USD
CY2020	us-gaap	Increase Decrease In Pension Plan Obligations IncreaseDecreaseInPensionPlanObligations	-32700000	USD
CY2021	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	1300000	USD
CY2020	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-1400000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	50000000.0	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	67100000	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1200000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1400000	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1200000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1400000	USD
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	42100000	USD
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	23100000	USD
CY2021	us-gaap	Payments For Repurchase Of Preferred Stock And Preference Stock PaymentsForRepurchaseOfPreferredStockAndPreferenceStock	44400000	USD
CY2020	us-gaap	Payments For Repurchase Of Preferred Stock And Preference Stock PaymentsForRepurchaseOfPreferredStockAndPreferenceStock	61600000	USD
CY2021	us-gaap	Repayments Of Debt RepaymentsOfDebt	6100000	USD
CY2020	us-gaap	Repayments Of Debt RepaymentsOfDebt	6100000	USD
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	900000	USD
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	300000	USD
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2400000	USD
CY2020	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	USD
CY2021	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	0	USD
CY2020	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	100000	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-9900000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-44400000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	38900000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	21300000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	157900000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	136600000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	196800000	USD
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	157900000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	-336900000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	54400000	USD
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	23100000	USD
CY2020	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	-61600000	USD
CY2020	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	-300000	USD
CY2020	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	700000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-320600000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	175000000.0	USD
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	42100000	USD
CY2021	leu	Exchange Of Preferred Stock For Common Stock And Common Stock Warrant ExchangeOfPreferredStockForCommonStockAndCommonStockWarrant	0	USD
CY2021	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	-44400000	USD
CY2021	leu	Reclassification Of Stock Based Compensation From Liability To Equity ReclassificationOfStockBasedCompensationFromLiabilityToEquity	7500000	USD
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2400000	USD
CY2021	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	-300000	USD
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1200000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-141900000	USD
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts presented and disclosed in the consolidated financial statements. Significant estimates and judgments include, but are not limited to, revenue and related costs, asset valuations, pension and postretirement health and life benefit costs and obligations, the tax bases of assets and liabilities, the future recoverability of deferred tax assets, and determination of the valuation allowance for deferred tax assets. Actual results may differ from such estimates, and estimates may change if the underlying conditions or assumptions change.</span></div>
CY2021	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P15Y
CY2021	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Concentrations of Credit Risk</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Credit risk could result from the possibility of a customer failing to perform or pay according to the terms of a contract. Extension of credit is based on an evaluation of each customer’s financial condition. Centrus regularly monitors credit risk exposure and takes steps intended to mitigate the likelihood of such exposure resulting in a loss.</span></div>
CY2021	us-gaap	Concentration Risk Supplier ConcentrationRiskSupplier	Concentrations of Supply Risk and Other Considerations with the War in Ukraine The current war in Ukraine has led to the U.S., Russia and other countries imposing sanctions and other measures that restrict international trade. The situation is rapidly changing, and it is not possible to predict future actions that could be taken. The Company has multiple sources of supply; however, the supply contract with TENEX remains our largest source. At present, sanctions have not impacted the ability of the Company or TENEX to perform under the TENEX supply contract. Recently, sanctions have been imposed by the U.S. on exports of fossil fuels. Russia has imposed sanctions on the export of commodities but does not include the export of LEU. Additional sanctions or other measures by the U.S. or foreign governments (including the Russian government) could be imposed. Any sanctions or measures directed at trade in LEU from Russia or the parties involved in such trade or otherwise could interfere with, or prevent, implementation of the TENEX Supply Contract. While the initial sanctions announced do not affect the ability of the Company or TENEX to implement the TENEX Supply Contract, the situation at this time is unpredictable and therefore there is no assurance that future developments would not have a material adverse effect on the Company’s procurement, payment, delivery or sale of LEU under the TENEX Supply Contract. If measures were taken to limit the supply of Russian LEU or to prohibit or limit dealings with Russian entities, including, but not limited to, TENEX or ROSATOM, the Company would seek a license, waiver or other approval from the government imposing such measures to ensure that the Company could continue to fulfill its purchase and sales obligations. There is no assurance that such a license, waiver, or approval would be granted. If a license, waiver or approval were not granted, the Company would need to look to alternative sources of LEU to replace the LEU that it could not procure from TENEX. The Company has contracts for alternative sources that could be used to mitigate a portion of the near term impacts. However, to the extent these sources were insufficient or more expensive or additional supply cannot be obtained, it could have a material adverse impact on our business, results of operations, and competitive position.
CY2021	us-gaap	Related Party Transaction Description Of Transaction RelatedPartyTransactionDescriptionOfTransaction	Related Party As previously disclosed in our Current Report on Form 8-K filed on December 31, 2020, on that same date theCompany entered into an At Market Sales Agreement (the “Sales Agreement”) with B. Riley Securities, Inc. andLake Street Capital Markets, LLC (the “Agents”), relating to the at the market offering (the “ATM Offering”) ofshares of the Company’s Class A Common Stock, $0.10 par value per share. Mr. Williams, Chairman of the CentrusBoard of Directors, also serves on the board of B. Riley Financial, Inc. Mr. Williams recused himself and took nopart in the selection of B. Riley or the negotiation of the terms of the Sales Agreement. Please refer to Note 15 - Stockholders’ Equity for a description of the ATM Offering in 2021.
CY2020	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	32600000	USD
CY2021Q4	us-gaap	Billed Contract Receivables BilledContractReceivables	23100000	USD
CY2020Q4	us-gaap	Billed Contract Receivables BilledContractReceivables	23000000.0	USD
CY2021Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	6000000.0	USD
CY2020Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	6600000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	29100000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	29600000	USD
CY2021Q4	us-gaap	Provision For Loss On Contracts ProvisionForLossOnContracts	500000	USD
CY2020Q4	us-gaap	Provision For Loss On Contracts ProvisionForLossOnContracts	7000000.0	USD
CY2021	leu	Provision For Loss On Contract Change ProvisionForLossOnContractChange	-6500000	USD
CY2021Q4	leu	Provisionforlossoncontractsnoncurrent Provisionforlossoncontractsnoncurrent	0	USD
CY2020Q4	leu	Provisionforlossoncontractsnoncurrent Provisionforlossoncontractsnoncurrent	700000	USD
CY2021	leu	Provision For Loss On Contracts Noncurrent Change ProvisionForLossOnContractsNoncurrentChange	-700000	USD
CY2021Q4	us-gaap	Deferred Revenue DeferredRevenue	288100000	USD
CY2020Q4	us-gaap	Deferred Revenue DeferredRevenue	281700000	USD
CY2021	leu	Deferred Revenue Change DeferredRevenueChange	6400000	USD
CY2021Q4	leu	Contract With Customer Advances Liability Current ContractWithCustomerAdvancesLiabilityCurrent	15000000.0	USD
CY2020Q4	leu	Contract With Customer Advances Liability Current ContractWithCustomerAdvancesLiabilityCurrent	1500000	USD
CY2021	leu	Advances From Customers Change AdvancesFromCustomersChange	13500000	USD
CY2021Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	45100000	USD
CY2020Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	45200000	USD
CY2021	leu	Advances From Customers Noncurrent Change AdvancesFromCustomersNoncurrentChange	-100000	USD
CY2021	leu	Deferred Revenue Additions In Period DeferredRevenueAdditionsInPeriod	47200000	USD
CY2020	leu	Deferred Revenue Additions In Period DeferredRevenueAdditionsInPeriod	38700000	USD
CY2021	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	42600000	USD
CY2020	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	44400000	USD
CY2021	leu	Provision For Loss On Contracts Utilized ProvisionForLossOnContractsUtilized	7200000	USD
CY2020	leu	Provision For Loss On Contracts Utilized ProvisionForLossOnContractsUtilized	10600000	USD
	leu	Provision For Loss On Contracts Utilized ProvisionForLossOnContractsUtilized	19100000	USD
CY2020	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	0	USD
CY2021Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	986000000	USD
CY2020Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	960000000	USD
CY2021Q4	leu	Deferred Revenue And Advances From Customers Current And Noncurrent DeferredRevenueAndAdvancesFromCustomersCurrentAndNoncurrent	348200000	USD
CY2021	us-gaap	Nonmonetary Transaction Gross Operating Revenue Recognized NonmonetaryTransactionGrossOperatingRevenueRecognized	23400000	USD
CY2021	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	59600000	USD
CY2021Q4	leu	Provision For Loss ProvisionForLoss	500000	USD
CY2021	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	43500000	USD
CY2021	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	43500000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	193800000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	152000000.0	USD
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	200000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	200000	USD
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	2800000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	5700000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	196800000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	157900000	USD
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	200000	USD
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	2800000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	200000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	5700000	USD
CY2021Q4	leu	Uranium Inventory Net Of Liability UraniumInventoryNetOfLiability	73900000	USD
CY2020Q4	leu	Uranium Inventory UraniumInventory	47800000	USD
CY2021Q4	leu	Separative Work Units Inventory SeparativeWorkUnitsInventory	8800000	USD
CY2021Q4	leu	Separative Work Units Owed To Customers And Suppliers SeparativeWorkUnitsOwedToCustomersAndSuppliers	0	USD
CY2021Q4	leu	Separative Work Units Net Of Liability SeparativeWorkUnitsNetOfLiability	8800000	USD
CY2020Q4	leu	Separative Work Units Inventory SeparativeWorkUnitsInventory	17000000.0	USD
CY2020Q4	leu	Separative Work Units Owed To Customers And Suppliers SeparativeWorkUnitsOwedToCustomersAndSuppliers	4600000	USD
CY2020Q4	leu	Separative Work Units Net Of Liability SeparativeWorkUnitsNetOfLiability	12400000	USD
CY2021Q4	leu	Uranium Inventory UraniumInventory	82300000	USD
CY2021Q4	leu	Uranium Owed To Customers And Suppliers UraniumOwedToCustomersAndSuppliers	8400000	USD
CY2020Q4	leu	Uranium Owed To Customers And Suppliers UraniumOwedToCustomersAndSuppliers	300000	USD
CY2020Q4	leu	Uranium Inventory Net Of Liability UraniumInventoryNetOfLiability	47500000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	91100000	USD
CY2021Q4	leu	Inventories Owed To Customers And Suppliers InventoriesOwedToCustomersAndSuppliers	8400000	USD
CY2021Q4	leu	Inventory Net Of Liability InventoryNetOfLiability	82700000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	64800000	USD
CY2020Q4	leu	Inventories Owed To Customers And Suppliers InventoriesOwedToCustomersAndSuppliers	4900000	USD
CY2020Q4	leu	Inventory Net Of Liability InventoryNetOfLiability	59900000	USD
	leu	Separative Work Units Borrowed In Period Value SeparativeWorkUnitsBorrowedInPeriodValue	20700000	USD
CY2021Q3	leu	Separativeworkunitsowedtoothersnoncurrent Separativeworkunitsowedtoothersnoncurrent	25500000	USD
CY2021	leu	Separative Work Units Repaid In Period Value SeparativeWorkUnitsRepaidInPeriodValue	3100000	USD
CY2021Q4	leu	Separativeworkunitsowedtoothersnoncurrent Separativeworkunitsowedtoothersnoncurrent	22400000	USD
CY2021	leu	Separative Work Units Valuation Change In Period SeparativeWorkUnitsValuationChangeInPeriod	4800000	USD
CY2020	us-gaap	Depreciation Depreciation	500000	USD
CY2021	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P15Y
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7600000	USD
CY2021	us-gaap	Property Plant And Equipment Additions PropertyPlantAndEquipmentAdditions	700000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	8300000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2700000	USD
CY2021	us-gaap	Accumulated Depreciation Depletion And Amortization Sale Of Property Plant And Equipment1 AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment1	300000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3000000.0	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4900000	USD
CY2021	leu	Property Plant And Equipment Net Capital Expenditures PropertyPlantAndEquipmentNetCapitalExpenditures	400000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5300000	USD
CY2021	us-gaap	Depreciation Depreciation	600000	USD
CY2021Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	123500000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	68800000	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	54700000	USD
CY2020Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	123500000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	60700000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	62800000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	9500000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	6600000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	8600000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	7600000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	9900000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	12500000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	54700000	USD
CY2021Q4	leu	Compensation And Benefits Payable CompensationAndBenefitsPayable	23100000	USD
CY2021Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	4900000	USD
CY2020Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	4900000	USD
CY2020Q4	leu	Compensation And Benefits Payable CompensationAndBenefitsPayable	22200000	USD
CY2021Q4	us-gaap	Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Current PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent	7000000.0	USD
CY2020Q4	us-gaap	Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Current PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent	11600000	USD
CY2021Q4	us-gaap	Provision For Loss On Contracts ProvisionForLossOnContracts	500000	USD
CY2020Q4	us-gaap	Provision For Loss On Contracts ProvisionForLossOnContracts	7000000.0	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	900000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2400000	USD
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1400000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2500000	USD
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	37800000	USD
CY2020Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	50600000	USD
CY2021Q4	leu	Subordinationtocreditfacilityfacilitytotal Subordinationtocreditfacilityfacilitytotal	50000000	USD
CY2021Q4	leu	Subordinationtocreditfacilityfacilitymaximumnetborrowing Subordinationtocreditfacilityfacilitymaximumnetborrowing	40000000	USD
CY2021Q4	leu	Subordinationtocreditfacilityfacilitytotal Subordinationtocreditfacilityfacilitytotal	50000000	USD
CY2021Q4	leu	Subordinationtocreditfacilityfacilitymaximumnetborrowing Subordinationtocreditfacilityfacilitymaximumnetborrowing	40000000	USD
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y3M18D
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.125
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	500000	USD
CY2020	us-gaap	Operating Lease Expense OperatingLeaseExpense	2600000	USD
CY2020	us-gaap	Operating Lease Expense OperatingLeaseExpense	2600000	USD
CY2021	leu	Operatingleaseexpenseadjustment Operatingleaseexpenseadjustment	2000000	USD
CY2020	leu	Operatingleaseexpenseadjustment Operatingleaseexpenseadjustment	300000	USD
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	2400000	USD
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	2400000	USD
CY2021	leu	Operating Lease Liability Decrease OperatingLeaseLiabilityDecrease	1000000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2100000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	900000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3000000.0	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	3900000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1300000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1000000.0	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1000000.0	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1000000.0	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1000000.0	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	800000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	6100000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	2200000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	3900000	USD
CY2021	leu	Pension Plan Assets Transferred For Annuitization PensionPlanAssetsTransferredForAnnuitization	30400000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	193800000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	152000000.0	USD
CY2021Q4	us-gaap	Cash Surrender Value Fair Value Disclosure CashSurrenderValueFairValueDisclosure	3200000	USD
CY2020Q4	us-gaap	Cash Surrender Value Fair Value Disclosure CashSurrenderValueFairValueDisclosure	2400000	USD
CY2021Q4	us-gaap	Fair Value Liabilities Measured On Recurring Basis Obligations FairValueLiabilitiesMeasuredOnRecurringBasisObligations	3200000	USD
CY2020Q4	us-gaap	Fair Value Liabilities Measured On Recurring Basis Obligations FairValueLiabilitiesMeasuredOnRecurringBasisObligations	2300000	USD
CY2021	leu	Pension Plan Obligations Transferred For Annuitization PensionPlanObligationsTransferredForAnnuitization	30400000	USD
CY2021	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	43500000	USD
CY2021Q4	us-gaap	Defined Benefit Plan Health Care Cost Trend Rate Assumed Next Fiscal Year DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear	0.060
CY2020Q4	us-gaap	Defined Benefit Plan Health Care Cost Trend Rate Assumed Next Fiscal Year DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear	0.055
CY2021Q4	us-gaap	Defined Benefit Plan Ultimate Health Care Cost Trend Rate1 DefinedBenefitPlanUltimateHealthCareCostTrendRate1	0.05
CY2020Q4	us-gaap	Defined Benefit Plan Ultimate Health Care Cost Trend Rate1 DefinedBenefitPlanUltimateHealthCareCostTrendRate1	0.05
CY2021	us-gaap	Defined Benefit Plan Year Health Care Cost Trend Rate Reaches Ultimate Trend Rate DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate	2026
CY2020	us-gaap	Defined Benefit Plan Year Health Care Cost Trend Rate Reaches Ultimate Trend Rate DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate	2022
CY2021Q4	us-gaap	Defined Benefit Plan Weighted Average Asset Allocations DefinedBenefitPlanWeightedAverageAssetAllocations	1
CY2020Q4	us-gaap	Defined Benefit Plan Weighted Average Asset Allocations DefinedBenefitPlanWeightedAverageAssetAllocations	1
CY2021Q4	leu	Defined Benefit Plan Investments Measured At Nav DefinedBenefitPlanInvestmentsMeasuredAtNAV	20100000	USD
CY2020Q4	leu	Defined Benefit Plan Investments Measured At Nav DefinedBenefitPlanInvestmentsMeasuredAtNAV	504400000	USD
CY2021Q4	leu	Accruedinterestreceivable Accruedinterestreceivable	1200000	USD
CY2020Q4	leu	Accruedinterestreceivable Accruedinterestreceivable	1300000	USD
CY2021Q4	leu	Unsettledtransactionsreceivable Unsettledtransactionsreceivable	-1400000	USD
CY2021	leu	Stock Appreciation Rights Expense StockAppreciationRightsExpense	11600000	USD
CY2020Q4	leu	Unsettledtransactionsreceivable Unsettledtransactionsreceivable	-1800000	USD
CY2021Q4	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	681800000	USD
CY2020Q4	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	633000000.0	USD
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	2000000	USD
CY2020	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1600000	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	700000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	1900000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	844293	shares
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	400000	USD
CY2021	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P12M
CY2020	leu	Stock Appreciation Rights Expense StockAppreciationRightsExpense	6600000	USD
CY2021	us-gaap	Restricted Stock Expense RestrictedStockExpense	500000	USD
CY2020	us-gaap	Restricted Stock Expense RestrictedStockExpense	400000	USD
CY2021	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	100000	USD
CY2020	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	100000	USD
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	12200000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7100000	USD
CY2021	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	-1500000	USD
CY2020	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0	USD
CY2021Q4	leu	Board Restricted Stock Units Potentially Converted To Common Stock Shares BoardRestrictedStockUnitsPotentiallyConvertedToCommonStockShares	192000	shares
CY2021Q4	leu	Employee Restricted Stock Units Potentially Converted To Common Stock Shares EmployeeRestrictedStockUnitsPotentiallyConvertedToCommonStockShares	4000	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	518000	shares
CY2019Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	4.02
CY2019	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P6Y2M12D
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1500000	USD
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	107000	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	3.43
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	411000	shares
CY2020Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	4.18
CY2020	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P5Y3M18D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	7800000	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	217000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	4.17
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	194000	shares
CY2021Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	4.18
CY2021	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P4Y4M24D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	8900000	USD
CY2021Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	144000	shares
CY2021Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	4.37
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y2M12D
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	6600000	USD
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	400000	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	500000	USD
CY2021	us-gaap	Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability	-39500000	USD
CY2020	us-gaap	Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability	-1900000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-39100000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1400000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits	36200000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits	61800000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	18600000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	16200000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	191500000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	193800000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	206200000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	211100000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	400000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	2100000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	10800000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	12600000	USD
CY2021Q4	leu	Deferred Tax Asset Lease Liability DeferredTaxAssetLeaseLiability	900000	USD
CY2020Q4	leu	Deferred Tax Asset Lease Liability DeferredTaxAssetLeaseLiability	1500000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	200000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	200000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	464800000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	499300000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	414700000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	486000000.0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	50100000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	13300000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	7900000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	9900000	USD
CY2021Q4	leu	Deferred Tax Liability Lease Asset DeferredTaxLiabilityLeaseAsset	400000	USD
CY2020Q4	leu	Deferred Tax Liability Lease Asset DeferredTaxLiabilityLeaseAsset	1100000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Other Capitalized Costs DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts	400000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Other Capitalized Costs DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts	400000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	8700000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	11400000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	41400000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	1900000	USD
CY2021Q4	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-40700000	USD
CY2021Q4	us-gaap	Valuation Allowance Deferred Tax Asset Explanation Of Change ValuationAllowanceDeferredTaxAssetExplanationOfChange	federal net deferred taxes that are more likely than not to be realized
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.53
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-30600000	USD
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Explanation Of Change ValuationAllowanceDeferredTaxAssetExplanationOfChange	changes in deferred tax assets since the beginning of the year
CY2020	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	39500000	USD
CY2020	us-gaap	Valuation Allowance Deferred Tax Asset Explanation Of Change ValuationAllowanceDeferredTaxAssetExplanationOfChange	previously unrecorded state deferred tax assets
CY2017Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	732000000	USD
CY2021Q4	leu	Operating Loss Carryforwards No Expiration OperatingLossCarryforwardsNoExpiration	131400000	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.26
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.01
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.02
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.01
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	0
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	0.01
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.29
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.03
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	71300000	USD
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	13900000	USD
CY2021Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	1000000	USD
CY2020Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	800000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Income Tax Penalties Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense	200000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Income Tax Penalties Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense	400000	USD
CY2020Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	800000	USD
CY2019Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	400000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	400000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	500000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	200000	USD
CY2021Q4	us-gaap	Payments For Repurchase Of Preferred Stock And Preference Stock PaymentsForRepurchaseOfPreferredStockAndPreferenceStock	43300000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	100000	USD
CY2021Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	1000000.0	USD
CY2020Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	800000	USD
CY2021Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	100000	USD
CY2020Q4	us-gaap	Payments For Repurchase Of Preferred Stock And Preference Stock PaymentsForRepurchaseOfPreferredStockAndPreferenceStock	60000000	USD
CY2020Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	21.62
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1.00
CY2020Q4	leu	Preferred Stock Liquidation Amount Per Share PreferredStockLiquidationAmountPerShare	1291.04	USD
CY2021Q4	leu	Stock Repurchase Price Per Share StockRepurchasePricePerShare	1149.99	USD
CY2021Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1.00
CY2021	leu	Aggregate Value Preferred Stock Transactions AggregateValuePreferredStockTransactions	50800000	USD
CY2021	us-gaap	Other Preferred Stock Dividends And Adjustments OtherPreferredStockDividendsAndAdjustments	37600000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	175000000.0	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	54400000	USD
CY2021	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	2100000	USD
CY2020	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	6700000	USD
CY2021	us-gaap	Other Preferred Stock Dividends And Adjustments OtherPreferredStockDividendsAndAdjustments	37600000	USD
CY2021	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	37600000	USD
CY2020	us-gaap	Other Preferred Stock Dividends And Adjustments OtherPreferredStockDividendsAndAdjustments	41900000	USD
CY2020	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	41900000	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	135300000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	5800000	USD
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13493000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9825000	shares
CY2021	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	386000	shares
CY2020	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	298000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13879000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10123000	shares
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	10.03
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.59
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	9.75
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.57
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1.00
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14369133	shares
CY2021	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	1516467	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	700000	shares
CY2021	leu	Preferred Stock Retired Liquidation Preference PreferredStockRetiredLiquidationPreference	5000198	USD
CY2021Q4	leu	Conversion Of Stock Share Price ConversionOfStockSharePrice	21.62
CY2021Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	21.62
CY2021	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	0	shares
CY2020	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	398262	shares
CY2016Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	1900000	shares
CY2021Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	844293	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	104574	shares
CY2021Q4	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	1000
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1.00
CY2021Q4	leu	Preferred Stock Liquidation Amount Per Share PreferredStockLiquidationAmountPerShare	1347.29	USD
CY2021Q4	us-gaap	Payments For Repurchase Of Preferred Stock And Preference Stock PaymentsForRepurchaseOfPreferredStockAndPreferenceStock	42200000	USD
CY2021Q4	us-gaap	Payments For Repurchase Of Preferred Stock And Preference Stock PaymentsForRepurchaseOfPreferredStockAndPreferenceStock	1100000	USD
CY2021Q4	us-gaap	Payments For Repurchase Of Preferred Stock And Preference Stock PaymentsForRepurchaseOfPreferredStockAndPreferenceStock	43300000	USD
CY2021Q4	leu	Common Stock Ownership Enabling Preferred Stock Purchase Rights CommonStockOwnershipEnablingPreferredStockPurchaseRights	0.0499
CY2021Q4	leu	Common Stock Ownership Enabling Preferred Stock Purchase Rights Incremental CommonStockOwnershipEnablingPreferredStockPurchaseRightsIncremental	0.005
CY2021Q4	us-gaap	Loss Contingency Range Of Possible Loss Portion Not Accrued LossContingencyRangeOfPossibleLossPortionNotAccrued	9600000	USD
CY2020Q4	us-gaap	Gain Contingency Unrecorded Amount GainContingencyUnrecordedAmount	42800000	USD
CY2021	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	43500000	USD
CY2021	us-gaap	Litigation Settlement Amount Awarded From Other Party LitigationSettlementAmountAwardedFromOtherParty	43500000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	298300000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	247200000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	298300000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	247200000	USD
CY2021	us-gaap	Gross Profit GrossProfit	114500000	USD
CY2020	us-gaap	Gross Profit GrossProfit	97600000	USD

Files In Submission

Name	View Source	Status
0001065059-22-000012-index-headers.html	Edgar Link	pending
0001065059-22-000012-index.html	Edgar Link	pending
0001065059-22-000012.txt	Edgar Link	pending
0001065059-22-000012-xbrl.zip	Edgar Link	pending
exhibit21-listofsubsidiari.htm	Edgar Link	pending
exhibit_10-30x20211231.htm	Edgar Link	pending
exhibit_10-50x20211231.htm	Edgar Link	pending
exhibit_23-1x20211231.htm	Edgar Link	pending
exhibit_31-1x20211231.htm	Edgar Link	pending
exhibit_31-2x20211231.htm	Edgar Link	pending
exhibit_32-1x20211231.htm	Edgar Link	pending
exhibit_4-16x20211231.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
image_0a.jpg	Edgar Link	pending
image_1.jpg	Edgar Link	pending
image_3a.jpg	Edgar Link	pending
image_5.jpg	Edgar Link	pending
image_6a.jpg	Edgar Link	pending
leu-20211231.htm	Edgar Link	pending
leu-20211231.xsd	Edgar Link	pending
leu-20211231_cal.xml	Edgar Link	unprocessable
leu-20211231_def.xml	Edgar Link	unprocessable
leu-20211231_g1.jpg	Edgar Link	pending
leu-20211231_g2.jpg	Edgar Link	pending
leu-20211231_htm.xml	Edgar Link	completed
leu-20211231_lab.xml	Edgar Link	unprocessable
leu-20211231_pre.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LEU
CENTRUS ENERGY CORP Stock $leu

2021 Q4 Form 10-K Financial Statement

#000106505922000012 Filed on March 11, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LEU CENTRUS ENERGY CORP Stock $leu

2021 Q4 Form 10-K Financial Statement

#000106505922000012 Filed on March 11, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LEU
CENTRUS ENERGY CORP Stock $leu